126 related articles for article (PubMed ID: 33967152)
1. [A loss-of-function mutation in exon1 of limited HLA class I alleles is common in patients with aplastic anemia].
Mizumaki H
Rinsho Ketsueki; 2021; 62(4):270-277. PubMed ID: 33967152
[TBL] [Abstract][Full Text] [Related]
2. A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia.
Mizumaki H; Hosomichi K; Hosokawa K; Yoroidaka T; Imi T; Zaimoku Y; Katagiri T; Anh Thi Nguyen M; Cao Tran D; Ibrahim Yousef Elbadry M; Chonabayashi K; Yoshida Y; Takamatsu H; Ozawa T; Azuma F; Kishi H; Fujii Y; Ogawa S; Tajima A; Nakao S
Haematologica; 2021 Jun; 106(6):1581-1590. PubMed ID: 32439725
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of detecting human leukocyte antigen class I allele-lacking leukocytes in aplastic anemia].
Hosokawa K; Nakao S
Rinsho Ketsueki; 2022; 63(8):899-905. PubMed ID: 36058861
[TBL] [Abstract][Full Text] [Related]
4. [Immune pathophysiology of bone marrow failure].
Hosokawa K
Rinsho Ketsueki; 2023; 64(9):908-915. PubMed ID: 37793865
[TBL] [Abstract][Full Text] [Related]
5. Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia.
Zaimoku Y; Takamatsu H; Hosomichi K; Ozawa T; Nakagawa N; Imi T; Maruyama H; Katagiri T; Kishi H; Tajima A; Muraguchi A; Kashiwase K; Nakao S
Blood; 2017 May; 129(21):2908-2916. PubMed ID: 28232583
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.
Katagiri T; Sato-Otsubo A; Kashiwase K; Morishima S; Sato Y; Mori Y; Kato M; Sanada M; Morishima Y; Hosokawa K; Sasaki Y; Ohtake S; Ogawa S; Nakao S;
Blood; 2011 Dec; 118(25):6601-9. PubMed ID: 21963603
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia.
Maruyama H; Katagiri T; Kashiwase K; Shiina T; Sato-Otsubo A; Zaimoku Y; Maruyama K; Hosokawa K; Ishiyama K; Yamazaki H; Inoko H; Ogawa S; Nakao S
Exp Hematol; 2016 Oct; 44(10):931-939.e3. PubMed ID: 27250585
[TBL] [Abstract][Full Text] [Related]
8. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
Zaimoku Y; Patel BA; Adams SD; Shalhoub R; Groarke EM; Lee AAC; Kajigaya S; Feng X; Rios OJ; Eager H; Alemu L; Quinones Raffo D; Wu CO; Flegel WA; Young NS
Blood; 2021 Dec; 138(26):2799-2809. PubMed ID: 34724566
[TBL] [Abstract][Full Text] [Related]
9. Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.
Imi T; Katagiri T; Hosomichi K; Zaimoku Y; Hoang Nguyen V; Nakagawa N; Tajima A; Yoshizato T; Ogawa S; Nakao S
Blood Adv; 2018 May; 2(9):1000-1012. PubMed ID: 29720492
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.
Olson TS; Frost BF; Duke JL; Dribus M; Xie HM; Prudowsky ZD; Furutani E; Gudera J; Shah YB; Ferriola D; Dinou A; Pagkrati I; Kim S; Xu Y; He M; Zheng S; Nijim S; Lin P; Xu C; Nakano TA; Oved JH; Carreno BM; Bolon YT; Gadalla SM; Marsh SG; Paczesny S; Lee SJ; Monos DS; Shimamura A; Bertuch AA; Gragert L; Spellman SR; Babushok DV
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36219480
[TBL] [Abstract][Full Text] [Related]
11. HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic Anemia.
Zaimoku Y; Katagiri T; Nakagawa N; Imi T; Maruyama H; Takamatsu H; Ishiyama K; Yamazaki H; Miyamoto T; Nakao S
Transplant Cell Ther; 2024 Mar; 30(3):281.e1-281.e13. PubMed ID: 37972732
[TBL] [Abstract][Full Text] [Related]
12. Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack.
Espinoza JL; Elbadry MI; Chonabayashi K; Yoshida Y; Katagiri T; Harada K; Nakagawa N; Zaimoku Y; Imi T; Takamatsu H; Ozawa T; Maruyama H; Hassanein HA; Khalifa A Noreldin A; Takenaka K; Akashi K; Hamana H; Kishi H; Akatsuka Y; Nakao S
Blood Adv; 2018 Feb; 2(4):390-400. PubMed ID: 29472446
[TBL] [Abstract][Full Text] [Related]
13. Detection of 6pLOH in an aplastic anemia patient by in phase HLA genotyping.
Kikkawa E; Shiina T; Shigenari A; Ozaki Y; Suzuki S; Ando K; Onizuka M
HLA; 2020 May; 95(5):465-469. PubMed ID: 31970935
[TBL] [Abstract][Full Text] [Related]
14. [Acquired aplastic anemia].
Hosokawa K; Nakao S
Rinsho Ketsueki; 2019; 60(5):417-422. PubMed ID: 31168007
[TBL] [Abstract][Full Text] [Related]
15. [Acquired aplastic anemia: recent advances in pathophysiology and treatment].
Yamazaki H
Rinsho Ketsueki; 2018; 59(6):711-715. PubMed ID: 29973449
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between polymorphism of HLA-A, -B, -DRB1 alleles and susceptibility of children to acquired aplastic anemia].
Lu SY; Xiao LL; Luo M; Zhang BH; Chen C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):120-4. PubMed ID: 22391180
[TBL] [Abstract][Full Text] [Related]
17. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia.
Nakao S; Takamatsu H; Chuhjo T; Ueda M; Shiobara S; Matsuda T; Kaneshige T; Mizoguchi H
Blood; 1994 Dec; 84(12):4257-61. PubMed ID: 7994040
[TBL] [Abstract][Full Text] [Related]
18. Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
Tsuji N; Hosokawa K; Urushihara R; Tanabe M; Zaimoku Y; Katagiri T; Ozawa T; Takamatsu H; Ishiyama K; Yamazaki H; Kishi H; Ogawa S; Nakao S
Leukemia; 2022 Jun; 36(6):1666-1675. PubMed ID: 35474098
[TBL] [Abstract][Full Text] [Related]
19. Origins and relatedness of human leukocyte antigen class I allele supertypes.
Naugler C
Hum Immunol; 2010 Sep; 71(9):837-42. PubMed ID: 20600449
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of immune pathophysiology in patients with bone marrow failure.
Nakao S
Int J Hematol; 2024 Mar; 119(3):231-239. PubMed ID: 36609840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
